Mineralys Therapeutics, Inc. (MLYS) at a glance

Mineralys Therapeutics, Inc. (MLYS) is a Healthcare company. It trades at $23.91. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (36/100).

Price
$23.91
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$12.59 to $47.65
Vestovix Score49/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
36